Evidence map›Paper›PMID 37848625›Full record

ReviewOncogene2023

p63: a crucial player in epithelial stemness regulation.

Yanan Li, Sara Giovannini, Tingting Wang, Jiankai Fang, Peishan Li, Changshun Shao, Ying Wang, TOR centre, Yufang Shi, Eleonora Candi and 2 more

Open access · hybridAbstract readReview
In one paragraph

Review in Oncogene, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
15.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. WWOX maintains epidermal identity and suppresses EMT to prevent aggressive cutaneous squamous cell carcinoma.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. DAPL1 is activated by Np63 and GRα and regulates lipid metabolism.Journal of molecular medicine (Berlin, Germany) · 2026
    Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Yanan LiDepartment of Experimental Medicine, TOR, University of Rome Tor Vergata, 00133, Rome, Italy.
Sara GiovanniniDepartment of Experimental Medicine, TOR, University of Rome Tor Vergata, 00133, Rome, Italy.
Tingting WangThe Third Affiliated Hospital of Soochow University, Institutes for Translational Medicine, Soochow University, Suzhou, 215000, China.
Jiankai FangThe Third Affiliated Hospital of Soochow University, Institutes for Translational Medicine, Soochow University, Suzhou, 215000, China.
Peishan LiThe Third Affiliated Hospital of Soochow University, Institutes for Translational Medicine, Soochow University, Suzhou, 215000, China.ORCID 0000-0002-6881-396X
Changshun ShaoThe Third Affiliated Hospital of Soochow University, Institutes for Translational Medicine, Soochow University, Suzhou, 215000, China.ORCID 0000-0003-2618-9342
Ying WangShanghai Institute of Nutrition and Health, Shanghai, 200031, China.ORCID 0000-0002-2571-9367
TOR centre
Yufang ShiThe Third Affiliated Hospital of Soochow University, Institutes for Translational Medicine, Soochow University, Suzhou, 215000, China. yfshi@suda.edu.cn.
Eleonora CandiDepartment of Experimental Medicine, TOR, University of Rome Tor Vergata, 00133, Rome, Italy. candi@uniroma2.it.ORCID 0000-0001-8332-4825
Gerry MelinoDepartment of Experimental Medicine, TOR, University of Rome Tor Vergata, 00133, Rome, Italy. melino@uniroma2.it.ORCID 0000-0001-9428-5972
Francesca BernassolaDepartment of Experimental Medicine, TOR, University of Rome Tor Vergata, 00133, Rome, Italy. bernasso@uniroma2.it.ORCID 0000-0002-8883-8654
University of Rome Tor Vergata · ITSoochow University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNShanghai Institute of Nutrition and Health · CN

Funding

Associazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research) IG 2019 - 23232Associazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research) IG 2019 - ID. 22206Associazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research) IG 2022 - ID. 27366Regione Lazio (Region of Lazio) LazioInnova Progetto Gruppo di Ricerca n 85-2017-14986; n 33 & 55-2021-T0002E0001
6 · The paper itself

Abstract

Epithelial tissue homeostasis is closely associated with the self-renewal and differentiation behaviors of epithelial stem cells (ESCs). p63, a well-known marker of ESCs, is an indispensable factor for their biological activities during epithelial development. The diversity of p63 isoforms expressed in distinct tissues allows this transcription factor to have a wide array of effects. p63 coordinates the transcription of genes involved in cell survival, stem cell self-renewal, migration, differentiation, and epithelial-to-mesenchymal transition. Through the regulation of these biological processes, p63 contributes to, not only normal epithelial development, but also epithelium-derived cancer pathogenesis. In this review, we provide an overview of the role of p63 in epithelial stemness regulation, including self-renewal, differentiation, proliferation, and senescence. We describe the differential expression of TAp63 and ΔNp63 isoforms and their distinct functional activities in normal epithelial tissues and in epithelium-derived tumors. Furthermore, we summarize the signaling cascades modulating the TAp63 and ΔNp63 isoforms as well as their downstream pathways in stemness regulation.

Indexed as

NeoplasmsTumor Suppressor ProteinsEpitheliumHumansPhosphoproteinsProtein IsoformsTranscription FactorsPhosphoproteinsProtein IsoformsTranscription FactorsTumor Suppressor Proteins

Identifiers

PMID37848625
PMCPMC10638092
OpenAlexW4387707628

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.